CompletedPhase 2NCT02363452
Reverse Transcriptase Inhibitors in AGS
Studying Aicardi-Goutières syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Yanick CROW, MD, PhDHôpital Necker - Enfants Malades Public Hospitals of Paris
- Intervention
- Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2015 – 2018
Study locations (1)
- Hôpital Necker - Enfants Malades, Paris, France
Collaborators
URC-CIC Paris Descartes Necker Cochin
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02363452 on ClinicalTrials.gov